การติดเชื้อเร็วหลังการผ่าตัดข้อเข่าเทียมจากเชื้อมัยโคแบคทีเรียม ฟอร์ทูอิทุม: รายงานผู้ป่วยและทบทวนวรรณกรรม
Article Sidebar
เผยแพร่แล้ว:
ส.ค. 17, 2019
Main Article Content
บทคัดย่อ
การติดเชื้อของข้อเทียมเป็นภาวะแทรกซ้อนที่ก่อให้เกิดความเสียหายอย่างมากหลังการผ่าตัดข้อเข่าเทียม การติดเชื้อมัยโคแบคทีเรียที่ไม่ใช่เชื้อวัณโรคพบได้น้อยมากในผู้ป่วยติดเชื้อหลังผ่าตัดข้อเข่าเทียม มีเพียงผู้ป่วยเพียงไม่กี่รายที่ได้รับการรายงานจากการสืบค้นวรรณกรรมทั้งหมดในปัจจุบัน ซึ่งเชื้อมัยโคแบคทีเรียม ฟอร์ทูอิทุมเป็นสมาชิกหนึ่งในกลุ่มมัยโคแบคทีเรียที่ไม่ใช่เชื้อวัณโรคและยังเป็นที่รู้จักในนามของเชื้อมัยโคแบคทีเรียที่เจริญเร็วอีกด้วย
ในรายงานผู้ป่วยฉบับนี้ ได้กล่าวถึงผู้ป่วยติดเชื้อหลังผ่าตัดข้อเข่าเทียมด้วยเชื้อมัยโคแบคทีเรียม ฟอร์ทูอิทุม โดยเริ่มมีอาการเพียง 3 สัปดาห์หลังการผ่าตัด จากการทบทวนวรรณกรรมที่ผ่านมา การรักษาผู้ป่วยในกลุ่มนี้แนะนำ two-stage exchange arthroplasty แต่คณะผู้วิจัยประสบความสำเร็จในการรักษาโดยผ่าตัดล้างข้อเข่าเทียมและเก็บข้อเทียมเดิมไว้ได้ ร่วมกับมีการให้ยาปฏิชีวนะระยะยาวที่เหมาะสม ผลการรักษาที่ 6 เดือนหลังผ่าตัด ผู้ป่วยมีการใช้งานของข้อเทียมกลับมาดีเยี่ยมเป็นที่น่าพอใจและไม่พบอาการแสดงของการติดเชื้อซ้ำ
Article Details
ประเภทบทความ
รายงานผู้ป่วย
เอกสารอ้างอิง
1. Runyon EH. Anonymous mycobacteria in pulmonary disease. Med Clin North Am. 1959; 43(1): 273-90.
2. Brown-Elliott BA, Wallace RJ. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev. 2002; 15(4): 716-46.
3. Buser GL, Laidler MR, Cassidy PM, Moulton-Meissner H, Beldavs ZG, Cieslak PR. Outbreak of Nontuberculous Mycobacteria Joint Prosthesis Infections, Oregon, USA, 2010-2016. Emerg Infect Dis. 2019; 25(5): 849.
4. Cruz JDC, de Janeiro AMR. Mycobacterium Fortuitum: A new acid-fast bacillus pathogenic for man. Acta Med Rio de Janeiro. 1938; 1: 297.
5. Eid AJ, Berbari EF, Sia IG, Wengenack NL, Osmon DR, Razonable RR. Prosthetic joint infection due to rapidly growing mycobacteria: report of 8 cases and review of the literature. Clin Infect Dis. 2007; 45(6): 687-94.
6. Porat MD, Austin MS. Bilateral knee periprosthetic infection with Mycobacterium fortuitum. J Arthroplasty. 2008; 23(5): 787-9.
7. Parvizi J, Fassihi SC, Enayatollahi MA. Diagnosis of periprosthetic joint infection following hip and knee arthroplasty. Orthop Clin North Am. 2016; 47(3): 505-15.
8. Larsen LH, Lange J, Xu Y, Schønheyder HC. Optimizing culture methods for diagnosis of prosthetic joint infections: a summary of modifications and improvements reported since 1995. J Med Microbiol. 2012; 61(Pt 3): 309-16.
9. Devi DG, Indumathi V, Indira S, Babu PS, Sridharan D, Belwadi MS. Injection site abscess due to Mycobacterium fortuitum: a case report. Indian J Med Microbiol. 2003; 21(2): 133-4.
10. Dross IC, Abbatiello AA, Jenney FS, Cohen AC. Pulmonary infection due to M. fortuitum. Am Rev Respir Dis. 1964; 89: 923-5.
11. Wunsh SE, Boyle GL, Leopold IA, Littman ML. Mycobacterium fortuitum infection of corneal graft. Arch Ophthalmol. 1969; 82(5): 602-7.
12. Carson LA, Petersen NJ, Favero MS, Aguero SM. Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants. Appl Environ Microbiol. 1978; 36(6): 839-46.
13. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev. 2003; 16(2): 319-54.
14. Steingrube VA, Gibson JL, Brown BA, Zhang Y, Wilson RW, Rajagopalan M, et al. PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria. J Clin Microbiol. 1995; 33(1): 149-53.
15. Control CfD, Prevention. Nontuberculous mycobacterial infections after cosmetic surgery--Santo Domingo, Dominican Republic, 2003-2004. MMWR Morb Mortal Wkly Rep. 2004; 53(23): 509.
16. Wallace Jr RJ, Musser JM, Hull SI, Silcox VA, Steele LC, Forrester GD, et al. Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery. J Infect Dis. 1989; 159(4): 708-16.
17. Henry MW, Miller AO, Kahn B, Windsor RE, Brause BD. Prosthetic joint infections secondary to rapidly growing mycobacteria: Two case reports and a review of the literature. Infect Dis (Lond). 2016; 48(6): 453-60.
18. Jitmuang A, Yuenyongviwat V, Charoencholvanich K, Chayakulkeeree M. Rapidly-growing mycobacterial infection: a recognized cause of early-onset prosthetic joint infection. BMC Infect Dis. 2017; 17(1): 802.
19. Sungkanuparph S, Sathapatayavongs B, Pracharktam R. Rapidly growing mycobacterial infections: spectrum of diseases, antimicrobial susceptibility, pathology and treatment outcomes. J Med Assoc Thai. 2003; 86(8): 772-80.
20. Silcox VA, Good RC, Floyd MM. Identification of clinically significant Mycobacterium fortuitum complex isolates. J Clin Microbiol. 1981; 14(6): 686-91.
21. Muthusami JC, Vyas FL, Mukundan U, Jesudason MR, Govil S, Jesudason SB. Mycobacterium fortuitum: an iatrogenic cause of soft tissue infection in surgery. ANZ J Surg. 2004; 74(8): 662-6.
22. Brown BA, Wallace RJ Jr, Onyi GO, De Rosas V, Wallace RJ 3rd. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother. 1992; 36(1): 180-4.
23. Nash KA, Zhang Y, Brown-Elliott BA, Wallace RJ Jr. Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J Antimicrob Chemother. 2005; 55(2): 170-7.
24. Schinsky MF, Morey RE, Steigerwalt AG, Douglas MP, Wilson RW, Floyd MM, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates. Int J Syst Evol Microbiol. 2004; 54(Pt 5): 1653-67.
25. Han XY, Dé I, Jacobson KL. Rapidly growing mycobacteria: clinical and microbiologic studies of 115 cases. Am J Clin Pathol. 2007; 128(4): 612-21.
26. Wallace RJ, Brown BA, Onyi GO. Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother. 1991; 35(4): 773-5.
27. Wang SX, Yang CJ, Chen YC, Lay CJ, Tsai CC. Septic arthritis caused by Mycobacterium fortuitum and Mycobacterium abscessus in a prosthetic knee joint: case report and review of literature. I Intern Med. 2011; 50(19): 2227-32.
28. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007; 175(4): 367-416.
29. Cheung I, Wilson A. Mycobacterium fortuitum infection following total knee arthroplasty: a case report and literature review. Knee. 2008; 15(1): 61-3.
30. Cornelius L, Reddix R, Burchett C, Bond G, Fader R. Cluster of Mycobacterium fortuitum prosthetic joint infections. J Surg Orthop Adv. 2007; 16(4): 196-8.
31. Venter R, Solomon C, Baartman M. Mycobacterium fortuitum as infectious agent in a septic total knee replacement: Case study and literature review. SA Orthop J. 2015; 14(2): 52-6.
32. Herold RC, Lotke PA, MacGregor RR. Prosthetic joint infections secondary to rapidly growing Mycobacterium fortuitum. Clin Orthop Relat Res. 1987; (216): 183-6.
33. Saccente M. Mycobacterium fortuitum group periprosthetic joint infection. Scand J Infect Dis. 2006; 38(8): 737-9.
34. Booth JE, Jacobson J, Kurrus TA, Edwards TW. Infection of prosthetic arthroplasty by Mycobacterium fortuitum. J Bone Joint Surg Am. 1979; 61(2): 300-2.
2. Brown-Elliott BA, Wallace RJ. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev. 2002; 15(4): 716-46.
3. Buser GL, Laidler MR, Cassidy PM, Moulton-Meissner H, Beldavs ZG, Cieslak PR. Outbreak of Nontuberculous Mycobacteria Joint Prosthesis Infections, Oregon, USA, 2010-2016. Emerg Infect Dis. 2019; 25(5): 849.
4. Cruz JDC, de Janeiro AMR. Mycobacterium Fortuitum: A new acid-fast bacillus pathogenic for man. Acta Med Rio de Janeiro. 1938; 1: 297.
5. Eid AJ, Berbari EF, Sia IG, Wengenack NL, Osmon DR, Razonable RR. Prosthetic joint infection due to rapidly growing mycobacteria: report of 8 cases and review of the literature. Clin Infect Dis. 2007; 45(6): 687-94.
6. Porat MD, Austin MS. Bilateral knee periprosthetic infection with Mycobacterium fortuitum. J Arthroplasty. 2008; 23(5): 787-9.
7. Parvizi J, Fassihi SC, Enayatollahi MA. Diagnosis of periprosthetic joint infection following hip and knee arthroplasty. Orthop Clin North Am. 2016; 47(3): 505-15.
8. Larsen LH, Lange J, Xu Y, Schønheyder HC. Optimizing culture methods for diagnosis of prosthetic joint infections: a summary of modifications and improvements reported since 1995. J Med Microbiol. 2012; 61(Pt 3): 309-16.
9. Devi DG, Indumathi V, Indira S, Babu PS, Sridharan D, Belwadi MS. Injection site abscess due to Mycobacterium fortuitum: a case report. Indian J Med Microbiol. 2003; 21(2): 133-4.
10. Dross IC, Abbatiello AA, Jenney FS, Cohen AC. Pulmonary infection due to M. fortuitum. Am Rev Respir Dis. 1964; 89: 923-5.
11. Wunsh SE, Boyle GL, Leopold IA, Littman ML. Mycobacterium fortuitum infection of corneal graft. Arch Ophthalmol. 1969; 82(5): 602-7.
12. Carson LA, Petersen NJ, Favero MS, Aguero SM. Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants. Appl Environ Microbiol. 1978; 36(6): 839-46.
13. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev. 2003; 16(2): 319-54.
14. Steingrube VA, Gibson JL, Brown BA, Zhang Y, Wilson RW, Rajagopalan M, et al. PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria. J Clin Microbiol. 1995; 33(1): 149-53.
15. Control CfD, Prevention. Nontuberculous mycobacterial infections after cosmetic surgery--Santo Domingo, Dominican Republic, 2003-2004. MMWR Morb Mortal Wkly Rep. 2004; 53(23): 509.
16. Wallace Jr RJ, Musser JM, Hull SI, Silcox VA, Steele LC, Forrester GD, et al. Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery. J Infect Dis. 1989; 159(4): 708-16.
17. Henry MW, Miller AO, Kahn B, Windsor RE, Brause BD. Prosthetic joint infections secondary to rapidly growing mycobacteria: Two case reports and a review of the literature. Infect Dis (Lond). 2016; 48(6): 453-60.
18. Jitmuang A, Yuenyongviwat V, Charoencholvanich K, Chayakulkeeree M. Rapidly-growing mycobacterial infection: a recognized cause of early-onset prosthetic joint infection. BMC Infect Dis. 2017; 17(1): 802.
19. Sungkanuparph S, Sathapatayavongs B, Pracharktam R. Rapidly growing mycobacterial infections: spectrum of diseases, antimicrobial susceptibility, pathology and treatment outcomes. J Med Assoc Thai. 2003; 86(8): 772-80.
20. Silcox VA, Good RC, Floyd MM. Identification of clinically significant Mycobacterium fortuitum complex isolates. J Clin Microbiol. 1981; 14(6): 686-91.
21. Muthusami JC, Vyas FL, Mukundan U, Jesudason MR, Govil S, Jesudason SB. Mycobacterium fortuitum: an iatrogenic cause of soft tissue infection in surgery. ANZ J Surg. 2004; 74(8): 662-6.
22. Brown BA, Wallace RJ Jr, Onyi GO, De Rosas V, Wallace RJ 3rd. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother. 1992; 36(1): 180-4.
23. Nash KA, Zhang Y, Brown-Elliott BA, Wallace RJ Jr. Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J Antimicrob Chemother. 2005; 55(2): 170-7.
24. Schinsky MF, Morey RE, Steigerwalt AG, Douglas MP, Wilson RW, Floyd MM, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates. Int J Syst Evol Microbiol. 2004; 54(Pt 5): 1653-67.
25. Han XY, Dé I, Jacobson KL. Rapidly growing mycobacteria: clinical and microbiologic studies of 115 cases. Am J Clin Pathol. 2007; 128(4): 612-21.
26. Wallace RJ, Brown BA, Onyi GO. Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother. 1991; 35(4): 773-5.
27. Wang SX, Yang CJ, Chen YC, Lay CJ, Tsai CC. Septic arthritis caused by Mycobacterium fortuitum and Mycobacterium abscessus in a prosthetic knee joint: case report and review of literature. I Intern Med. 2011; 50(19): 2227-32.
28. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007; 175(4): 367-416.
29. Cheung I, Wilson A. Mycobacterium fortuitum infection following total knee arthroplasty: a case report and literature review. Knee. 2008; 15(1): 61-3.
30. Cornelius L, Reddix R, Burchett C, Bond G, Fader R. Cluster of Mycobacterium fortuitum prosthetic joint infections. J Surg Orthop Adv. 2007; 16(4): 196-8.
31. Venter R, Solomon C, Baartman M. Mycobacterium fortuitum as infectious agent in a septic total knee replacement: Case study and literature review. SA Orthop J. 2015; 14(2): 52-6.
32. Herold RC, Lotke PA, MacGregor RR. Prosthetic joint infections secondary to rapidly growing Mycobacterium fortuitum. Clin Orthop Relat Res. 1987; (216): 183-6.
33. Saccente M. Mycobacterium fortuitum group periprosthetic joint infection. Scand J Infect Dis. 2006; 38(8): 737-9.
34. Booth JE, Jacobson J, Kurrus TA, Edwards TW. Infection of prosthetic arthroplasty by Mycobacterium fortuitum. J Bone Joint Surg Am. 1979; 61(2): 300-2.
